蓝丰生化(002513) - 2022 Q3 - 季度财报

Financial Performance - Revenue for Q3 2022 was ¥267,445,171.54, a decrease of 39.95% compared to the same period last year[4] - Net profit attributable to shareholders was -¥10,553,027.29, a decline of 63.26% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥12,176,122.79, down 59.10% from the previous year[4] - Basic and diluted earnings per share were both -¥0.0282, a decrease of 64.72% compared to the same period last year[4] - The net profit attributable to the parent company was a loss of CNY 12,096,001.39, an improvement compared to a loss of CNY 42,229,317.91 in the previous period[19] - Basic and diluted earnings per share were both reported at -0.0323, an improvement from -0.1242 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,611,177,295.20, a decrease of 6.76% from the end of the previous year[4] - As of September 30, 2022, total current assets amounted to CNY 397,463,271.52, a decrease from CNY 546,039,989.40 at the beginning of the year, representing a decline of approximately 27.2%[14] - Total non-current assets reached CNY 1,213,714,023.68, an increase from CNY 1,181,909,973.11 at the start of the year, indicating a growth of about 2.7%[15] - The total assets of the company were CNY 1,611,177,295.20, down from CNY 1,727,949,962.51, reflecting a decrease of approximately 6.7%[15] - Total current liabilities were CNY 931,775,922.03, a reduction from CNY 1,045,237,076.35, showing a decline of around 10.9%[15] - The company's total liabilities amounted to CNY 943,063,196.72, down from CNY 1,061,312,988.31, representing a decrease of about 11.1%[15] - The company’s total equity attributable to shareholders reached CNY 668,114,098.48, slightly up from CNY 666,636,974.20[18] Cash Flow - Cash flow from operating activities showed a net outflow of -¥41,132,208.79, a significant decline of 171.07%[4] - Cash flow from operating activities showed a net outflow of CNY 41,132,208.79, contrasting with a net inflow of CNY 57,873,864.42 in the previous period[19] - The net cash flow from investment activities was 11,796,141.15, a significant improvement compared to -92,691,397.23 in the previous period[20] - Total cash inflow from financing activities reached 199,790,100.00, up from 136,000,000.00 in the prior period[20] - The net cash flow from financing activities was 5,929,296.41, contrasting with -96,660,240.95 in the previous period[20] - The cash and cash equivalents at the end of the period totaled 11,693,152.81, down from 95,348,563.04 at the end of the previous period[20] - The company experienced a net decrease in cash and cash equivalents of 21,273,873.63 during the quarter[20] - The total cash outflow from investment activities was 54,218,722.08, compared to 92,669,182.62 in the previous period[20] - The company received 101,550,000.00 in cash from investment absorption during the quarter[20] - The cash paid for debt repayment was 82,000,000.00, a decrease from 122,041,192.54 in the previous period[20] - The impact of exchange rate changes on cash and cash equivalents was 2,132,897.60, compared to 31,368.60 in the previous period[20] Shareholder Information - The top ten shareholders collectively hold 58.56% of the company's shares, with Jiangsu Suhua Group Co., Ltd. being the largest shareholder at 9.18%[12] - The company has no preferred shareholders as of the reporting period[13] Operational Activities - The company reported a 375.96% increase in other non-current assets, totaling ¥94,020,881.37 due to reclassification of long-term assets[9] - Research and development expenses decreased by 71.50% to ¥3,138,082.33 compared to the same period last year[10] - The company received government subsidies amounting to ¥3,210,265.53, an increase of 146.61% year-on-year[10] - The company reported a significant increase in cash received from the disposal of fixed assets, amounting to ¥6,014,863.23, a rise of 27176.16%[10] - Total operating revenue for the period reached CNY 1,091,224,761.19, a slight increase from CNY 1,085,671,226.21 in the previous period, representing a growth of approximately 0.5%[17] - Total operating costs decreased to CNY 1,120,927,109.52 from CNY 1,143,331,222.90, marking a reduction of about 2.0%[17] - Research and development expenses significantly decreased to CNY 3,138,082.33 from CNY 11,010,052.54, a reduction of approximately 71.5%[17] - Sales expenses were reduced to CNY 7,901,158.93 from CNY 24,103,059.75, indicating a decrease of about 67.2%[17] - The company reported a significant increase in other income to CNY 3,210,265.53 from CNY 1,301,750.00, representing a growth of approximately 146.4%[17] Audit Information - The third quarter report was not audited[21]